Research Paper Volume 15, Issue 17 pp 8851—8872
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
Figure 6. Receiver operating characteristic (ROC) curve for AKAP8L expression in pan-cancer. (A) ACC; (B) BRCA; (C) COAD; (D) CESC; (E) ESCA; (F) KIRC; (G) KICH; (H) HNSC; (I) LIHC; (J) LUAD; (K) OV; (L) READ; (M) SKCM; (N) STAD; (O) TGCT.